Patients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy
Public ClinicalTrials.gov record NCT01103323. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled Phase III Study of Regorafenib Plus BSC Versus Placebo Plus BSC in Patients With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double-blind, placebo-controlled multi-center phase III study to evaluate efficacy and safety of regorafenib in patients with metastatic colorectal cancer (CRC) who have progressed on/after all approved drugs for CRC
Study identification
- NCT ID
- NCT01103323
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 760 participants
Conditions and interventions
Conditions
Interventions
- Regorafenib (Stivarga, BAY73-4506) Drug
- Placebo Drug
- Best Supportive Care (BSC) Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2010 (Type not available)
- Primary completion
- Jul 2011 (Actual)
- Completion
- Jan 2014 (Actual)
- Last update posted
- Jun 24, 2015
2010 – 2014
United States locations
- U.S. sites
- 26
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Beverly Hills | California | 90211 | — |
| Not listed | Los Angeles | California | 90033 | — |
| Not listed | Los Angeles | California | 90036 | — |
| Not listed | Mission Hills | California | 91345 | — |
| Not listed | Orange | California | 92868 | — |
| Not listed | Redlands | California | 92374 | — |
| Not listed | Santa Maria | California | 93454 | — |
| Not listed | Aventura | Florida | 33180 | — |
| Not listed | Jacksonville | Florida | 32224 | — |
| Not listed | Peoria | Illinois | 61615-7828 | — |
| Not listed | Cedar Rapids | Iowa | 52403 | — |
| Not listed | New Orleans | Louisiana | 70121 | — |
| Not listed | Ann Arbor | Michigan | 48106 | — |
| Not listed | Rochester | Minnesota | 55905 | — |
| Not listed | Saint Cloud | Minnesota | 56303 | — |
| Not listed | Jefferson City | Missouri | 65109 | — |
| Not listed | Neptune City | New Jersey | 07754 | — |
| Not listed | New York | New York | 10011 | — |
| Not listed | Fargo | North Dakota | 58122 | — |
| Not listed | Toledo | Ohio | 43623 | — |
| Not listed | Scranton | Pennsylvania | 18510 | — |
| Not listed | Charleston | South Carolina | 29414 | — |
| Not listed | Sumter | South Carolina | 29150 | — |
| Not listed | Dallas | Texas | 75390-9110 | — |
| Not listed | Salt Lake City | Utah | 84106 | — |
| Not listed | Green Bay | Wisconsin | 54303 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 145 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01103323, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2015 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01103323 live on ClinicalTrials.gov.